AxoGen, Inc. (AXGN) PT Raised to $50 at Citizens on Q1 Results - Record sales, High Growth
Citizens analyst David Turkaly raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $50.00 (from $42.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)